CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise | +1,194 | $52.84 | $63K | 27,380 |
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise | +69 | $57.22 | $4K | 27,449 |
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise | +285 | $63.62 | $18K | 27,734 |
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise | +652 | $92.65 | $60K | 28,386 |
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise | +181 | $103.42 | $19K | 28,567 |
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −1,194 | 972 | ||
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −69 | 7,171 | ||
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −285 | 18,171 | ||
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −652 | 2,405 | ||
| 2025-12-16 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −181 | 4,186 | ||
| 2025-12-12 | Espinoza Octavio Chief Financial Officer | Sale | −1,804 | $188.31 | $340K | 26,186 |
| 2025-12-08 | Aryeh Jason Director | Option exercise | +2,034 | $69.51 | $141K | 71,323 |
| 2025-12-08 | Aryeh Jason Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,034 | 0 | ||
| 2025-12-05 | Espinoza Octavio Chief Financial Officer | Shares withheld for taxes | −1,862 | $184.87 | $344K | 27,990 |
| 2025-12-04 | Davis Todd C Chief Executive Officer | Gift | −130 | 161,337 | ||
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −92 | $193.86 | $18K | 44,496 |
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −179 | $194.76 | $35K | 44,317 |
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −47 | $195.80 | $9K | 44,270 |
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −4 | $196.35 | $785 | 44,266 |
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −92 | $197.72 | $18K | 44,174 |
Page 13 of 43 · 858 trades